SCHEMBL14369459

SCHEMBL14369459

CCCCCCCCC#CCCCCCCCC(C)=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN7 P35236 5/20 0.70
▸ HMGCR P04035 3/20 0.70
▸ TDP1 Q9NUW8 3/20 0.58
▸ RECQL P46063 2/20 0.58
▸ ALDH1A1 P00352 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ USP2 O75604 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ ALOX12 P18054 1/20 0.55
▸ BLM P54132 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ MCL1 Q07820 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ EPHX2 P34913 3/20 0.54
▸ CES2 O00748 3/20 0.50
▸ CES1 P23141 3/20 0.50
▸ SELP P16109 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5129481 1.00 PTPN7 (0.70) PTPN7HMGCRTDP1RECQLALDH1A1
SCHEMBL4655920 0.96 PTPN7 (0.64) PTPN7HMGCRTDP1RECQLALDH1A1
SCHEMBL15942925 0.92 HMGCR (0.72) PTPN7HMGCRTDP1RECQLALDH1A1
SCHEMBL28193875 0.89 CES2 (0.62) TDP1ALDH1A1MEN1KMT2ACES2
2-Dodecanone SCHEMBL23501396 0.86 CES2 (0.65) TDP1ALDH1A1MEN1KMT2ACES2
2-Nonanone SCHEMBL4485770 0.86 CES2 (0.65) TDP1ALDH1A1MEN1KMT2ACES2
SCHEMBL7618683 0.86 CES2 (0.65) TDP1ALDH1A1MEN1KMT2ACES2
SCHEMBL21044722 0.86 CES2 (0.65) TDP1ALDH1A1MEN1KMT2ACES2
2-Tridecanone SCHEMBL119126 0.86 CES2 (0.65) TDP1ALDH1A1MEN1KMT2ACES2
SCHEMBL6894926 0.86 CES2 (0.65) TDP1ALDH1A1MEN1KMT2ACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119490532-A Rhenium (V) carbaryl complexes and methods of use and preparation thereof 香港科技大学 2025-02-21 — — CN disclosed
US-20070248700-A1 Extractions and Methods Comprising Elder Species HERBALSCIENCE NUTRACEUTICALS, LLC 2007-10-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070248700-A1 Extractions and Methods Comprising Elder Species NOP58, MYC, MDM4 PTPN7 3060/4885HMGCR 217/4885TDP1 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback